Fatal Haemoptysis Associated with Dramatic Response to Crizotinib in an ALK-Rearranged Lung Adenocarcinoma
The presence of an ALK (Anaplastic Lymphoma Kinase) rearrangement is a rare molecular feature in Non-Small Cell Lung Carcinoma (NSCLC), and concerns mainly non- or light smokers, young patients, with adenocarcinoma histological type. These tumours are particularly sensitive to Alk-targeted therapi...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
JCDR Research and Publications Private Limited
2016-03-01
|
| Serija: | Journal of Clinical and Diagnostic Research |
| Teme: | |
| Online pristup: | https://jcdr.net/articles/PDF/7428/17805_CE(RA1)_F(T)_PF1(Vi_Om)_PFA(AK)_PF2(PP).pdf |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|